1,684 results on '"PETERSEN, P."'
Search Results
2. PELABELAN TOTAL (a,d) -TITIK-ANTIAJAIB SUPER PADA GRAF PETERSEN P(n,2) DENGAN n GANJIL (n>_5)
- Author
-
RIDO, AMAN and RIDO, AMAN
- Abstract
Penelitian ini bertujuan mengkaji tentang pelabelan total (a,d) -titik-antiajaib super pada Graf Petersen P(n,2)dengan n ganjil (n>_5) Kata kunci : Graf Petersen P(n,2), Pelabelan Total (a,d)-Titik-AntiAjaib Super
- Published
- 2013
3. PELABELAN TOTAL (a,d) -TITIK-ANTIAJAIB SUPER PADA GRAF PETERSEN P(n,2) DENGAN n GANJIL (n>_5)
- Author
-
RIDO, AMAN and RIDO, AMAN
- Abstract
Penelitian ini bertujuan mengkaji tentang pelabelan total (a,d) -titik-antiajaib super pada Graf Petersen P(n,2)dengan n ganjil (n>_5) Kata kunci : Graf Petersen P(n,2), Pelabelan Total (a,d)-Titik-AntiAjaib Super
- Published
- 2013
4. PELABELAN TOTAL SISI AJAIB PADA GRAF PETERSEN P(n; 1) UNTUK n GANJIL (n � 3) DENGAN KONSTANTA k = 1 2(11n + 3) ATAU k = 1 2(15n + 3)
- Author
-
RIDRA, MELISA and RIDRA, MELISA
- Abstract
Misal terdapat graf G = (V;E) dengan himpunan titik V (G) dan himpunan sisi E(G). Pelabelan total pada sisi-ajaib pada G adalah suatu pemetaan bijektif � : V (G) [ E(G)
- Published
- 2015
5. Fig. 1. [Modification à la voie d’accès Petersen-P. Mathieu sur l’articulation de la hanche pour la réduction à ciel ouvert et le vissage des fractures du col]
- Abstract
Référence de l'image dans la banque d'images : med90027x1928x0242. - Nombre d'images dans le lot : 1
- Published
- 1928
6. Short-term surgical complications following fast-track medial unicompartmental knee arthroplasty
- Author
-
Jensen, C. Bredgaard, Gromov, K., Petersen, P. B., Jørgensen, C. C., Kehlet, H., Troelsen, A., Jensen, C. Bredgaard, Gromov, K., Petersen, P. B., Jørgensen, C. C., Kehlet, H., and Troelsen, A.
- Abstract
Aims Medial unicompartmental knee arthroplasty (mUKA) is an advised treatment for anterome-dial knee osteoarthritis. While long-term survival after mUKA is well described, reported incidences of short-term surgical complications vary and the effect of surgical usage on complications is less established. We aimed to describe the overall occurrence and treatment of surgical complications within 90 days of mUKA, as well as occurrence in high-usage centres compared to low-usage centres. Methods mUKAs performed in eight fast-track centres from February 2010 to June 2018 were included from the Lundbeck Foundation Centre for Fast-track Hip and Knee Replacement Database. All readmissions within 90 days of surgery underwent chart review and readmissions related to the surgical wound or the prosthesis were recorded. Centres were categorized as high-usage centres when using mUKA in ≥ 20% of annual knee arthroplasties. The occurrence of complications between high-and low-usage centres were compared using Fisher’s exact test. Results We included 3,757 mUKAs: 2,377 mUKAs from high-usage centres and 1,380 mUKAs from low-usage centres. Surgical complications within 90 days occurred in 69 cases (1.8%), 45 (1.9%) in high-usage centres and 24 (1.7%) in low-usage centres (odds ratio (OR) 1.1 (95% confidence interval (CI) 0.65 to 1.8)). The most frequent complications were periprosthetic joint infections (PJIs) (n = 18; 0.48%), wound-related issues (n = 14; 0.37%), and peripros-thetic fractures (n = 13; 0.35%). Bearing dislocations (n = 7; 0.19%) occurred primarily in procedures from high-usage centres. In high-usage centres, seven periprosthetic fractures (0.29%) occurred compared to six (0.43%) in low-usage centres (OR 0.68 (95% CI 0.20 to 2.0)). In high-usage centres, nine PJIs (0.38%) occurred compared to nine (0.65%) in low-usage centres (OR 0.58 (95% CI 0.22 to 1.6)). Conclusion Surgical complications are rare after fast-track mUKA surgery and with no difference in overall occu
- Published
- 2023
7. Short-term surgical complications following fast-track medial unicompartmental knee arthroplasty
- Author
-
Jensen, C. Bredgaard, Gromov, K., Petersen, P. B., Jørgensen, C. C., Kehlet, H., Troelsen, A., Jensen, C. Bredgaard, Gromov, K., Petersen, P. B., Jørgensen, C. C., Kehlet, H., and Troelsen, A.
- Abstract
Aims Medial unicompartmental knee arthroplasty (mUKA) is an advised treatment for anterome-dial knee osteoarthritis. While long-term survival after mUKA is well described, reported incidences of short-term surgical complications vary and the effect of surgical usage on complications is less established. We aimed to describe the overall occurrence and treatment of surgical complications within 90 days of mUKA, as well as occurrence in high-usage centres compared to low-usage centres. Methods mUKAs performed in eight fast-track centres from February 2010 to June 2018 were included from the Lundbeck Foundation Centre for Fast-track Hip and Knee Replacement Database. All readmissions within 90 days of surgery underwent chart review and readmissions related to the surgical wound or the prosthesis were recorded. Centres were categorized as high-usage centres when using mUKA in ≥ 20% of annual knee arthroplasties. The occurrence of complications between high-and low-usage centres were compared using Fisher’s exact test. Results We included 3,757 mUKAs: 2,377 mUKAs from high-usage centres and 1,380 mUKAs from low-usage centres. Surgical complications within 90 days occurred in 69 cases (1.8%), 45 (1.9%) in high-usage centres and 24 (1.7%) in low-usage centres (odds ratio (OR) 1.1 (95% confidence interval (CI) 0.65 to 1.8)). The most frequent complications were periprosthetic joint infections (PJIs) (n = 18; 0.48%), wound-related issues (n = 14; 0.37%), and peripros-thetic fractures (n = 13; 0.35%). Bearing dislocations (n = 7; 0.19%) occurred primarily in procedures from high-usage centres. In high-usage centres, seven periprosthetic fractures (0.29%) occurred compared to six (0.43%) in low-usage centres (OR 0.68 (95% CI 0.20 to 2.0)). In high-usage centres, nine PJIs (0.38%) occurred compared to nine (0.65%) in low-usage centres (OR 0.58 (95% CI 0.22 to 1.6)). Conclusion Surgical complications are rare after fast-track mUKA surgery and with no difference in overall occu
- Published
- 2023
8. Dynamic Lighting and Natural Ventilation in Patient Rooms at New Psychiatry Bispebjerg
- Author
-
Volf, C., Martiny, K., Petersen, P. M., Corell, D. D., Dam-Hansen, C, Volf, C., Martiny, K., Petersen, P. M., Corell, D. D., and Dam-Hansen, C
- Abstract
This paper presents preliminary results of analyzes of the indoor environmental quality (IEQ) in a full scale rotatable 1:1 mockup of a patient room. As initial part of the planning of the indoor environment at a new mental hospital, the project seeks to uncover the natural differences and limitations of the building, caused by the geographical orientation. Examining the outdoor diurnal variations and their effect on the indoor environment, in order to create a balance between on the one hand, daylight and artificial lighting and on the other hand the demand for passive cooling, using natural ventilation. The analysis discuss potential health aspects of daylight and fresh air and proposes a new strategy for dynamic artificial lighting, including natural ventilation to supplement mechanical ventilation. In this article we uncover daylight conditions based on two main parameters; 1) the geographic orientation (N, S, E and W) and 2) the season (summer and winter). Based on the preliminary data and the regional daylight conditions, the article proposes a new way to plan the indoor environmental quality called Lattitude and Orientation Compensated Architectural Lighting (LOCAL).
- Published
- 2022
9. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia
- Author
-
Marin-Corral, J, Pascual-Guardia, S, Amati, F, Aliberti, S, Masclans, J, Soni, N, Rodriguez, A, Sibila, O, Sanz, F, Sotgiu, G, Anzueto, A, Dimakou, K, Petrino, R, van de Garde, E, Restrepo, M, Aruj, P, Attorri, S, Barimboim, E, Caeiro, J, Garzon, M, Cambursano, V, Adrian Ceccato, V, Chertcoff, J, Lascar, F, Di Tulio, F, Diaz, A, de Vedia, L, Ganaha, M, Lambert, S, Lopardo, G, Luna, C, Malberti, A, Morcillo, N, Tartara, S, Pensotti, C, Pereyra, B, Scapellato, P, Stagnaro, J, Shah, S, Lotsch, F, Thalhammer, F, Anseeuw, K, Francois, C, Van Braeckel, E, Vincent, J, Djimon, M, Bashi, J, Dodo, R, Nouer, S, Chipev, P, Encheva, M, Miteva, D, Petkova, D, Balkissou, A, Pefura Yone, E, Mbatchou Ngahane, B, Shen, N, Xu, J, Bustamante Rico, C, Buitrago, R, Pereira Paternina, F, Kayembe Ntumba, J, Carevic, V, Jakopovic, M, Jankovic, M, Matkovic, Z, Mitrecic, I, Bouchy Jacobsson, M, Christensen, A, Heitmann Bodtger, U, Meyer, C, Jensen, A, Baunbaek-knudsen, G, Petersen, P, Andersen, S, El-Said Abd El-Wahhab, I, Morsy, N, Shafiek, H, Sobh, E, Abdulsemed, K, Bertrand, F, Brun-Buisson, C, de Montmollin, E, Fartoukh, M, Messika, J, Tattevin, P, Khoury, A, Ebruke, B, Dreher, M, Kolditz, M, Meisinger, M, Pletz, M, Hagel, S, Rupp, J, Schaberg, T, Spielmanns, M, Creutz, P, Suttorp, N, Siaw-Lartey, B, Papapetrou, D, Tsigou, E, Ampazis, D, Kaimakamis, E, Bhatia, M, Dhar, R, D'Souza, G, Garg, R, Koul, P, Mahesh, P, Jayaraj, B, Narayan, K, Udnur, H, Krishnamurthy, S, Kant, S, Swarnakar, R, Limaye, S, Salvi, S, Golshani, K, Keatings, V, Martin-Loeches, I, Maor, Y, Strahilevitz, J, Faverio, P, Battaglia, S, Carrabba, M, Ceriana, P, Confalonieri, M, Monforte, A, Del Prato, B, De Rosa, M, Fantini, R, Fiorentino, G, Gammino, M, Menzella, F, Milani, G, Nava, S, Palmiero, G, Gabrielli, B, Rossi, P, Sorino, C, Steinhilber, G, Zanforlin, A, San Luca, O, Franzetti, F, Carugati, M, Morosi, M, Monge, E, Carone, M, Patella, V, Scarlata, S, Comel, A, Kurahashi, K, Bacha, Z, Ugalde, D, Zuniga, O, Villegas, J, Medenica, M, Mihsra, D, Shrestha, P, Ridgeon, E, Awokola, B, Adefuye Bolanle Olufunlola, O, Olumide, S, Ukwaja, K, Irfan, M, Minarowski, L, Szymon, S, Froes, F, Leuschner, P, Meireles, M, Ferrao, C, Neves, J, Abel, S, Ravara, S, Brocovschii, V, Rusu, D, Toma, C, Chirita, D, Dorobat, C, Birkun, A, Kaluzhenina, A, Almotairi, A, Ali Bukhary, Z, Edathodu, J, Fathy, A, Abdulaziz Enani, A, Mohamed, N, Memon, J, Bella, A, Bogdanovic, S, Milenkovic, B, Pesut, D, Borderias, L, Bordon Garcia, N, Alarcon, H, Cilloniz, C, Torres, A, Diaz-Brito, V, Casas, X, Gonzalez, A, Fernandez-Almira, M, Interna, M, Gallego, M, Gaspar-GarcIa, I, Gonzalez del Castillo, J, Victoria, P, Martinez, E, Malo de Molina, R, Marcos, P, Menendez, R, Pando-Sandoval, A, Aymerich, C, Lacoma de la Torre, A, Garcia-Olive, I, Rello, J, Moyano, S, Rodrigo-Troyano, A, Sole-Violan, J, Uranga, A, van Boven, J, Torra, E, Pujol, J, Feldman, C, Yum, H, Arnauld Attannon Fiogbe, I, Yangui, F, Bilaceroglu, S, Levent Dalar, I, Yilmaz, U, Bogomolov, A, Elahi, N, Dhasmana, D, Feneley, A, Hill, A, Rudran, B, Ruiz-Buitrago, S, Campbell, M, Whitaker, P, Youzguin, A, Singanayagam, A, Hancock, C, Villafuerte, D, Allen, K, Brito, V, Dietz, J, Dysart, C, Kellie, S, Ricardo, A, Meier, G, Gaga, M, Holland, T, Bergin, S, Kheir, F, Landmeier, M, Lois, M, Nair, G, Patel, H, Reyes, K, Rodriguez-Cintron, W, Saito, S, Noda, J, Hinojosa, C, Levine, S, Reyes, L, Angel, L, Whitlow, K, Hipskind, J, Sukhija, K, Totten, V, Wunderink, R, Shah, R, Mateyo, K, Noriega, L, Alvarado, E, Aman, M, Labra, L, Marin-Corral J., Pascual-Guardia S., Amati F., Aliberti S., Masclans J. R., Soni N., Rodriguez A., Sibila O., Sanz F., Sotgiu G., Anzueto A., Dimakou K., Petrino R., van de Garde E., Restrepo M. I., Aruj P. K., Attorri S., Barimboim E., Caeiro J. P., Garzon M. I., Cambursano V. H., Adrian Ceccato V. H. D. C. A., Chertcoff J., Lascar F., Di Tulio F., Diaz A. C., de Vedia L., Ganaha M. C., Lambert S., Lopardo G., Luna C. M., Malberti A. G., Morcillo N., Tartara S., Pensotti C., Pereyra B., Scapellato P. G., Stagnaro J. P., Shah S., Lotsch F., Thalhammer F., Anseeuw K., Francois C. A., Van Braeckel E., Vincent J. L., Djimon M. Z., Bashi J., Dodo R., Nouer S. A., Chipev P., Encheva M., Miteva D., Petkova D., Balkissou A. D., Pefura Yone E. W., Mbatchou Ngahane B. H., Shen N., Xu J. -F., Bustamante Rico C. A., Buitrago R., Pereira Paternina F. J., Kayembe Ntumba J. -M., Carevic V. V., Jakopovic M., Jankovic M., Matkovic Z., Mitrecic I., Bouchy Jacobsson M. -L., Christensen A. B., Heitmann Bodtger U. C., Meyer C. N., Jensen A. V., Baunbaek-knudsen G., Petersen P. T., Andersen S., El-Said Abd El-Wahhab I., Morsy N. E., Shafiek H., Sobh E., Abdulsemed K. A., Bertrand F., Brun-Buisson C., de Montmollin E., Fartoukh M., Messika J., Tattevin P., Khoury A., Ebruke B., Dreher M., Kolditz M., Meisinger M., Pletz M. W., Hagel S., Rupp J., Schaberg T., Spielmanns M., Creutz P., Suttorp N., Siaw-Lartey B., Papapetrou D., Tsigou E., Ampazis D., Kaimakamis E., Bhatia M., Dhar R., D'Souza G., Garg R., Koul P. A., Mahesh P. A., Jayaraj B. S., Narayan K. V., Udnur H. B., Krishnamurthy S. B., Kant S., Swarnakar R., Limaye S., Salvi S., Golshani K., Keatings V. M., Martin-Loeches I., Maor Y., Strahilevitz J., Faverio P., Battaglia S., Carrabba M., Ceriana P., Confalonieri M., Monforte A. D., Del Prato B., De Rosa M., Fantini R., Fiorentino G., Gammino M. A., Menzella F., Milani G., Nava S., Palmiero G., Gabrielli B., Rossi P., Sorino C., Steinhilber G., Zanforlin A., San Luca O., Franzetti F., Carugati M., Morosi M., Monge E., Carone M., Patella V., Scarlata S., Comel A., Kurahashi K., Bacha Z. A., Ugalde D. B., Zuniga O. C., Villegas J. F., Medenica M., Mihsra D. R., Shrestha P., Ridgeon E., Awokola B. I., Adefuye Bolanle Olufunlola O. N. O., Olumide S., Ukwaja K. N., Irfan M., Minarowski L., Szymon S., Froes F., Leuschner P., Meireles M., Ferrao C., Neves J., Abel Salazar, Ravara S. B., Brocovschii V., Rusu D., Toma C., Chirita D., Dorobat C. M., Birkun A., Kaluzhenina A., Almotairi A., Ali Bukhary Z. A., Edathodu J., Fathy A., Abdulaziz Enani A. M., Mohamed N. E., Memon J. U., Bella A., Bogdanovic S. N., Milenkovic B., Pesut D., Borderias L., Bordon Garcia N. M., Alarcon H. C., Cilloniz C., Torres A., Diaz-Brito V., Casas X., Gonzalez A. E., Fernandez-Almira M. L., Interna M., Gallego M., Gaspar-GarcIa I., Gonzalez del Castillo J., Victoria P. J., Martinez E. L., Malo de Molina R., Marcos P. J., Menendez R., Pando-Sandoval A., Aymerich C. P., Lacoma de la Torre A., Garcia-Olive I., Rello J., Moyano S., Rodrigo-Troyano A., Sole-Violan J., Uranga A., van Boven J. F., Torra E. V., Pujol J. A., Feldman C., Yum H. K., Arnauld Attannon Fiogbe I. U., Yangui F., Bilaceroglu S., Levent Dalar I. D., Yilmaz U., Bogomolov A., Elahi N., Dhasmana D. J., Feneley A., Hill A. T., Rudran B., Ruiz-Buitrago S., Campbell M., Whitaker P., Youzguin A., Singanayagam A., Hancock C., Villafuerte D., Allen K. S., Brito V., Dietz J., Dysart C. E., Kellie S. M., Ricardo A. Franco-Sadud C. J., Meier G., Gaga M., Holland T. L., Bergin S. P., Kheir F., Landmeier M., Lois M., Nair G. B., Patel H., Reyes K., Rodriguez-Cintron W., Saito S., Noda J., Hinojosa C. I., Levine S. M., Reyes L. F., Angel L. F., Whitlow K. S., Hipskind J., Sukhija K., Totten V., Wunderink R. G., Shah R. D., Mateyo K. J., Noriega L., Alvarado E., Aman M., Labra L., Marin-Corral, J, Pascual-Guardia, S, Amati, F, Aliberti, S, Masclans, J, Soni, N, Rodriguez, A, Sibila, O, Sanz, F, Sotgiu, G, Anzueto, A, Dimakou, K, Petrino, R, van de Garde, E, Restrepo, M, Aruj, P, Attorri, S, Barimboim, E, Caeiro, J, Garzon, M, Cambursano, V, Adrian Ceccato, V, Chertcoff, J, Lascar, F, Di Tulio, F, Diaz, A, de Vedia, L, Ganaha, M, Lambert, S, Lopardo, G, Luna, C, Malberti, A, Morcillo, N, Tartara, S, Pensotti, C, Pereyra, B, Scapellato, P, Stagnaro, J, Shah, S, Lotsch, F, Thalhammer, F, Anseeuw, K, Francois, C, Van Braeckel, E, Vincent, J, Djimon, M, Bashi, J, Dodo, R, Nouer, S, Chipev, P, Encheva, M, Miteva, D, Petkova, D, Balkissou, A, Pefura Yone, E, Mbatchou Ngahane, B, Shen, N, Xu, J, Bustamante Rico, C, Buitrago, R, Pereira Paternina, F, Kayembe Ntumba, J, Carevic, V, Jakopovic, M, Jankovic, M, Matkovic, Z, Mitrecic, I, Bouchy Jacobsson, M, Christensen, A, Heitmann Bodtger, U, Meyer, C, Jensen, A, Baunbaek-knudsen, G, Petersen, P, Andersen, S, El-Said Abd El-Wahhab, I, Morsy, N, Shafiek, H, Sobh, E, Abdulsemed, K, Bertrand, F, Brun-Buisson, C, de Montmollin, E, Fartoukh, M, Messika, J, Tattevin, P, Khoury, A, Ebruke, B, Dreher, M, Kolditz, M, Meisinger, M, Pletz, M, Hagel, S, Rupp, J, Schaberg, T, Spielmanns, M, Creutz, P, Suttorp, N, Siaw-Lartey, B, Papapetrou, D, Tsigou, E, Ampazis, D, Kaimakamis, E, Bhatia, M, Dhar, R, D'Souza, G, Garg, R, Koul, P, Mahesh, P, Jayaraj, B, Narayan, K, Udnur, H, Krishnamurthy, S, Kant, S, Swarnakar, R, Limaye, S, Salvi, S, Golshani, K, Keatings, V, Martin-Loeches, I, Maor, Y, Strahilevitz, J, Faverio, P, Battaglia, S, Carrabba, M, Ceriana, P, Confalonieri, M, Monforte, A, Del Prato, B, De Rosa, M, Fantini, R, Fiorentino, G, Gammino, M, Menzella, F, Milani, G, Nava, S, Palmiero, G, Gabrielli, B, Rossi, P, Sorino, C, Steinhilber, G, Zanforlin, A, San Luca, O, Franzetti, F, Carugati, M, Morosi, M, Monge, E, Carone, M, Patella, V, Scarlata, S, Comel, A, Kurahashi, K, Bacha, Z, Ugalde, D, Zuniga, O, Villegas, J, Medenica, M, Mihsra, D, Shrestha, P, Ridgeon, E, Awokola, B, Adefuye Bolanle Olufunlola, O, Olumide, S, Ukwaja, K, Irfan, M, Minarowski, L, Szymon, S, Froes, F, Leuschner, P, Meireles, M, Ferrao, C, Neves, J, Abel, S, Ravara, S, Brocovschii, V, Rusu, D, Toma, C, Chirita, D, Dorobat, C, Birkun, A, Kaluzhenina, A, Almotairi, A, Ali Bukhary, Z, Edathodu, J, Fathy, A, Abdulaziz Enani, A, Mohamed, N, Memon, J, Bella, A, Bogdanovic, S, Milenkovic, B, Pesut, D, Borderias, L, Bordon Garcia, N, Alarcon, H, Cilloniz, C, Torres, A, Diaz-Brito, V, Casas, X, Gonzalez, A, Fernandez-Almira, M, Interna, M, Gallego, M, Gaspar-GarcIa, I, Gonzalez del Castillo, J, Victoria, P, Martinez, E, Malo de Molina, R, Marcos, P, Menendez, R, Pando-Sandoval, A, Aymerich, C, Lacoma de la Torre, A, Garcia-Olive, I, Rello, J, Moyano, S, Rodrigo-Troyano, A, Sole-Violan, J, Uranga, A, van Boven, J, Torra, E, Pujol, J, Feldman, C, Yum, H, Arnauld Attannon Fiogbe, I, Yangui, F, Bilaceroglu, S, Levent Dalar, I, Yilmaz, U, Bogomolov, A, Elahi, N, Dhasmana, D, Feneley, A, Hill, A, Rudran, B, Ruiz-Buitrago, S, Campbell, M, Whitaker, P, Youzguin, A, Singanayagam, A, Hancock, C, Villafuerte, D, Allen, K, Brito, V, Dietz, J, Dysart, C, Kellie, S, Ricardo, A, Meier, G, Gaga, M, Holland, T, Bergin, S, Kheir, F, Landmeier, M, Lois, M, Nair, G, Patel, H, Reyes, K, Rodriguez-Cintron, W, Saito, S, Noda, J, Hinojosa, C, Levine, S, Reyes, L, Angel, L, Whitlow, K, Hipskind, J, Sukhija, K, Totten, V, Wunderink, R, Shah, R, Mateyo, K, Noriega, L, Alvarado, E, Aman, M, Labra, L, Marin-Corral J., Pascual-Guardia S., Amati F., Aliberti S., Masclans J. R., Soni N., Rodriguez A., Sibila O., Sanz F., Sotgiu G., Anzueto A., Dimakou K., Petrino R., van de Garde E., Restrepo M. I., Aruj P. K., Attorri S., Barimboim E., Caeiro J. P., Garzon M. I., Cambursano V. H., Adrian Ceccato V. H. D. C. A., Chertcoff J., Lascar F., Di Tulio F., Diaz A. C., de Vedia L., Ganaha M. C., Lambert S., Lopardo G., Luna C. M., Malberti A. G., Morcillo N., Tartara S., Pensotti C., Pereyra B., Scapellato P. G., Stagnaro J. P., Shah S., Lotsch F., Thalhammer F., Anseeuw K., Francois C. A., Van Braeckel E., Vincent J. L., Djimon M. Z., Bashi J., Dodo R., Nouer S. A., Chipev P., Encheva M., Miteva D., Petkova D., Balkissou A. D., Pefura Yone E. W., Mbatchou Ngahane B. H., Shen N., Xu J. -F., Bustamante Rico C. A., Buitrago R., Pereira Paternina F. J., Kayembe Ntumba J. -M., Carevic V. V., Jakopovic M., Jankovic M., Matkovic Z., Mitrecic I., Bouchy Jacobsson M. -L., Christensen A. B., Heitmann Bodtger U. C., Meyer C. N., Jensen A. V., Baunbaek-knudsen G., Petersen P. T., Andersen S., El-Said Abd El-Wahhab I., Morsy N. E., Shafiek H., Sobh E., Abdulsemed K. A., Bertrand F., Brun-Buisson C., de Montmollin E., Fartoukh M., Messika J., Tattevin P., Khoury A., Ebruke B., Dreher M., Kolditz M., Meisinger M., Pletz M. W., Hagel S., Rupp J., Schaberg T., Spielmanns M., Creutz P., Suttorp N., Siaw-Lartey B., Papapetrou D., Tsigou E., Ampazis D., Kaimakamis E., Bhatia M., Dhar R., D'Souza G., Garg R., Koul P. A., Mahesh P. A., Jayaraj B. S., Narayan K. V., Udnur H. B., Krishnamurthy S. B., Kant S., Swarnakar R., Limaye S., Salvi S., Golshani K., Keatings V. M., Martin-Loeches I., Maor Y., Strahilevitz J., Faverio P., Battaglia S., Carrabba M., Ceriana P., Confalonieri M., Monforte A. D., Del Prato B., De Rosa M., Fantini R., Fiorentino G., Gammino M. A., Menzella F., Milani G., Nava S., Palmiero G., Gabrielli B., Rossi P., Sorino C., Steinhilber G., Zanforlin A., San Luca O., Franzetti F., Carugati M., Morosi M., Monge E., Carone M., Patella V., Scarlata S., Comel A., Kurahashi K., Bacha Z. A., Ugalde D. B., Zuniga O. C., Villegas J. F., Medenica M., Mihsra D. R., Shrestha P., Ridgeon E., Awokola B. I., Adefuye Bolanle Olufunlola O. N. O., Olumide S., Ukwaja K. N., Irfan M., Minarowski L., Szymon S., Froes F., Leuschner P., Meireles M., Ferrao C., Neves J., Abel Salazar, Ravara S. B., Brocovschii V., Rusu D., Toma C., Chirita D., Dorobat C. M., Birkun A., Kaluzhenina A., Almotairi A., Ali Bukhary Z. A., Edathodu J., Fathy A., Abdulaziz Enani A. M., Mohamed N. E., Memon J. U., Bella A., Bogdanovic S. N., Milenkovic B., Pesut D., Borderias L., Bordon Garcia N. M., Alarcon H. C., Cilloniz C., Torres A., Diaz-Brito V., Casas X., Gonzalez A. E., Fernandez-Almira M. L., Interna M., Gallego M., Gaspar-GarcIa I., Gonzalez del Castillo J., Victoria P. J., Martinez E. L., Malo de Molina R., Marcos P. J., Menendez R., Pando-Sandoval A., Aymerich C. P., Lacoma de la Torre A., Garcia-Olive I., Rello J., Moyano S., Rodrigo-Troyano A., Sole-Violan J., Uranga A., van Boven J. F., Torra E. V., Pujol J. A., Feldman C., Yum H. K., Arnauld Attannon Fiogbe I. U., Yangui F., Bilaceroglu S., Levent Dalar I. D., Yilmaz U., Bogomolov A., Elahi N., Dhasmana D. J., Feneley A., Hill A. T., Rudran B., Ruiz-Buitrago S., Campbell M., Whitaker P., Youzguin A., Singanayagam A., Hancock C., Villafuerte D., Allen K. S., Brito V., Dietz J., Dysart C. E., Kellie S. M., Ricardo A. Franco-Sadud C. J., Meier G., Gaga M., Holland T. L., Bergin S. P., Kheir F., Landmeier M., Lois M., Nair G. B., Patel H., Reyes K., Rodriguez-Cintron W., Saito S., Noda J., Hinojosa C. I., Levine S. M., Reyes L. F., Angel L. F., Whitlow K. S., Hipskind J., Sukhija K., Totten V., Wunderink R. G., Shah R. D., Mateyo K. J., Noriega L., Alvarado E., Aman M., and Labra L.
- Abstract
Background: Aspiration community-acquired pneumonia (ACAP) and community-acquired pneumonia (CAP) in patients with aspiration risk factors (AspRFs) are infections associated with anaerobes, but limited evidence suggests their pathogenic role. Research Question: What are the aspiration risk factors, microbiology patterns, and empiric anti-anaerobic use in patients hospitalized with CAP? Study Design and Methods: This is a secondary analysis of GLIMP, an international, multicenter, point-prevalence study of adults hospitalized with CAP. Patients were stratified into three groups: (1) ACAP, (2) CAP/AspRF+ (CAP with AspRF), and (3) CAP/AspRF- (CAP without AspRF). Data on demographics, comorbidities, microbiological results, and anti-anaerobic antibiotics were analyzed in all groups. Patients were further stratified in severe and nonsevere CAP groups. Results: We enrolled 2,606 patients with CAP, of which 193 (7.4%) had ACAP. Risk factors independently associated with ACAP were male, bedridden, underweight, a nursing home resident, and having a history of stroke, dementia, mental illness, and enteral tube feeding. Among non-ACAP patients, 1,709 (70.8%) had CAP/AspRF+ and 704 (29.2%) had CAP/AspRF-. Microbiology patterns including anaerobes were similar between CAP/AspRF-, CAP/AspRF+ and ACAP (0.0% vs 1.03% vs 1.64%). Patients with severe ACAP had higher rates of total gram-negative bacteria (64.3% vs 44.3% vs 33.3%, P =.021) and lower rates of total gram-positive bacteria (7.1% vs 38.1% vs 50.0%, P <.001) when compared with patients with severe CAP/AspRF+ and severe CAP/AspRF-, respectively. Most patients (>50% in all groups) independent of AspRFs or ACAP received specific or broad-spectrum anti-anaerobic coverage antibiotics. Interpretation: Hospitalized patients with ACAP or CAP/AspRF+ had similar anaerobic flora compared with patients without aspiration risk factors. Gram-negative bacteria were more prevalent in patients with severe ACAP. Despite having similar
- Published
- 2021
10. Interactions between folate intake and genetic predictors of gene expression levels associated with colorectal cancer risk
- Author
-
Haas, CB, Su, Y-R, Petersen, P, Wang, X, Bien, SA, Lin, Y, Albanes, D, Weinstein, SJ, Jenkins, MA, Figueiredo, JC, Newcomb, PA, Casey, G, Le Marchand, L, Campbell, PT, Moreno, V, Potter, JD, Sakoda, LC, Slattery, ML, Chan, AT, Li, L, Giles, GG, Milne, RL, Gruber, SB, Rennert, G, Woods, MO, Gallinger, SJ, Berndt, S, Hayes, RB, Huang, W-Y, Wolk, A, White, E, Nan, H, Nassir, R, Lindor, NM, Lewinger, JP, Kim, AE, Conti, D, Gauderman, WJ, Buchanan, DD, Peters, U, Hsu, L, Haas, CB, Su, Y-R, Petersen, P, Wang, X, Bien, SA, Lin, Y, Albanes, D, Weinstein, SJ, Jenkins, MA, Figueiredo, JC, Newcomb, PA, Casey, G, Le Marchand, L, Campbell, PT, Moreno, V, Potter, JD, Sakoda, LC, Slattery, ML, Chan, AT, Li, L, Giles, GG, Milne, RL, Gruber, SB, Rennert, G, Woods, MO, Gallinger, SJ, Berndt, S, Hayes, RB, Huang, W-Y, Wolk, A, White, E, Nan, H, Nassir, R, Lindor, NM, Lewinger, JP, Kim, AE, Conti, D, Gauderman, WJ, Buchanan, DD, Peters, U, and Hsu, L
- Abstract
Observational studies have shown higher folate consumption to be associated with lower risk of colorectal cancer (CRC). Understanding whether and how genetic risk factors interact with folate could further elucidate the underlying mechanism. Aggregating functionally relevant genetic variants in set-based variant testing has higher power to detect gene-environment (G × E) interactions and may provide information on the underlying biological pathway. We investigated interactions between folate consumption and predicted gene expression on colorectal cancer risk across the genome. We used variant weights from the PrediXcan models of colon tissue-specific gene expression as a priori variant information for a set-based G × E approach. We harmonized total folate intake (mcg/day) based on dietary intake and supplemental use across cohort and case-control studies and calculated sex and study specific quantiles. Analyses were performed using a mixed effects score tests for interactions between folate and genetically predicted expression of 4839 genes with available genetically predicted expression. We pooled results across 23 studies for a total of 13,498 cases with colorectal tumors and 13,918 controls of European ancestry. We used a false discovery rate of 0.2 to identify genes with suggestive evidence of an interaction. We found suggestive evidence of interaction with folate intake on CRC risk for genes including glutathione S-Transferase Alpha 1 (GSTA1; p = 4.3E-4), Tonsuko Like, DNA Repair Protein (TONSL; p = 4.3E-4), and Aspartylglucosaminidase (AGA: p = 4.5E-4). We identified three genes involved in preventing or repairing DNA damage that may interact with folate consumption to alter CRC risk. Glutathione is an antioxidant, preventing cellular damage and is a downstream metabolite of homocysteine and metabolized by GSTA1. TONSL is part of a complex that functions in the recovery of double strand breaks and AGA plays a role in lysosomal breakdown of glycoprotein.
- Published
- 2022
11. Between institutional reform and building popular movements : The political articulation of agroecology in Brazil
- Author
-
Van den Berg, L., Behagel, J.H., Verschoor, G., Petersen, P., Gomes da Silva, M., Van den Berg, L., Behagel, J.H., Verschoor, G., Petersen, P., and Gomes da Silva, M.
- Abstract
Agroecology is increasingly seen to contain solutions that can be used for wider societal transformation. While debates have mainly focused on reformist versus revolutionary strategies, less attention has been paid to how such strategies connect to peasant demands and how they can be combined for agroecological transformation. In this article we study transformation by the agroecology movement in Brazil through the theoretical lens of political articulation. We show that peasants’ local demands for land, alternative farming and local markets were mobilised in an institutional politics to gain policy support and in a populist politics to create movements that pose a systemic challenge to authority. We then argue that the political viability of wider societal transformation lies in the ability to create movements and organisations that politicise peasants and embrace local demands. We conclude that attention should not only be paid to individual strategies and their immediate effects but also on how diverse politics combine, to build the material and symbolic capacity of the movement and their potential for transformation over the long run.
- Published
- 2022
12. Recommendations on thromboprophylaxis in major joint arthroplasty - many guidelines, little consensus?
- Author
-
Jørgensen, C C, Petersen, P B, Reed, M, Kehlet, H, Jørgensen, C C, Petersen, P B, Reed, M, and Kehlet, H
- Abstract
Venous thromboembolic events remain a concern in total hip and knee arthroplasty. Consequently, several guidelines on thromboprophylaxis have been established. However, despite similarities in methodology for evaluation of evidence, discrepancies in guideline recommendations continue to exist. Furthermore, the results of older randomized clinical trials still have significant influence despite major improvements in perioperative care. In contrast, the results of recent large cohort studies with fewer thromboembolic events are mostly used only for background data. Here we outline some of the differences between the guidelines on thromboprophylaxis from the American College of Chest Physicians, the National Institute for Health and Care Excellence and the American Academy of Orthopedic Surgeons. We discuss differences in the methodology and focus of the guidelines potentially influencing the final recommendations. Future analyses are required, including data from modern care with early mobilization and short length of stay.
- Published
- 2019
13. Effect of pre-operative methylprednisolone on orthostatic hypotension during early mobilization after total hip arthroplasty
- Author
-
Lindberg-Larsen, V, Petersen, P B, Jans, Ø, Beck, T, Kehlet, H., Lindberg-Larsen, V, Petersen, P B, Jans, Ø, Beck, T, and Kehlet, H.
- Abstract
BACKGROUND: Orthostatic hypotension (OH) and intolerance (OI) are common after total hip arthroplasty (THA) and may delay early mobilization. The pathology of OH and OI includes a dysregulated post-operative vasopressor response, by a hitherto unknown mechanism. We hypothesized that OI could be related to the inflammatory stress response which is inhibited by steroid administration. Consequently, this study evaluated the effect of a pre-operative high-dose methylprednisolone on OH and OI early after THA.METHODS: Randomized, double-blind, placebo-controlled study in 59 patients undergoing elective unilateral THA with spinal anesthesia and a standardized multimodal analgesic regime. Patients were allocated (1 : 1) to pre-operative intravenous (IV) methylprednisolone (MP) 125 mg or isotonic saline (C). OH, OI and cardiovascular responses to sitting and standing were evaluated using a standardized mobilization protocol pre-operatively, 6, and 24 h after surgery. Systolic and diastolic arterial pressure and heart rate were measured non-invasively (Nexfin® ). The systemic inflammation was monitored by the C-reactive protein (CRP) response.RESULTS: At 6 h post-operatively, 11 (38%) versus 11 (37%) patients had OH in group MP and group C, respectively (RR 1.02 (0.60 to 1.75; P = 1.00)), whereas OI was present in 9 (31%) versus 13 (43%) patients (RR 0.76 (0.42 to 1.36; P = 0.42)), respectively. At 24 h post-operatively, the prevalence of OH and OI did not differ between groups, though CRP levels were significantly reduced in group MP (P < 0.001).CONCLUSION: Pre-operative administration of 125 mg methylprednisolone IV did not reduce OH or OI compared with placebo despite a reduced inflammatory response.
- Published
- 2018
14. SPCG-15:a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer
- Author
-
Stranne, J., Brasso, K., Brennhovd, B., Johansson, E., Jäderling, F., Kouri, M., Lilleby, W., Meidahl Petersen, P., Mirtti, T., Pettersson, A., Rannikko, A., Thellenberg, C., Akre, O., Stranne, J., Brasso, K., Brennhovd, B., Johansson, E., Jäderling, F., Kouri, M., Lilleby, W., Meidahl Petersen, P., Mirtti, T., Pettersson, A., Rannikko, A., Thellenberg, C., and Akre, O.
- Abstract
Objective: To describe study design and procedures for a prospective randomized trial investigating whether radical prostatectomy (RP) ± radiation improves cause-specific survival in comparison with primary radiation treatment (RT) and androgen deprivation treatment (ADT) in patients with locally advanced prostate cancer (LAPC). Materials and methods: SPCG-15 is a prospective, multi-centre, open randomized phase III trial. Patients are randomized to either standard (RT + ADT) or experimental (RP with extended pelvic lymph-node dissection and with addition of adjuvant or salvage RT and/or ADT if deemed necessary) treatment. Each centre follows guidelines regarding the timing and dosing of postoperative RT and adjuvant treatment such as ADT The primary endpoint is cause-specific survival. Secondary endpoints include metastasis-free and overall survival, quality-of-life, functional outcomes and health-services requirements. Each subject will be followed up for a minimum of 10 years. Results: Twenty-three centres in Denmark, Finland, Norway and Sweden, well established in performing RP and RT for prostate cancer participated. Each country’s sites were coordinated by national coordinating investigators and sub-investigators for urology and oncology. Almost 400 men have been randomized of the stipulated 1200, with an increasing rate of accrual. Conclusions: The SPCG-15 trial aims to compare the two curatively intended techniques supplying new knowledge to support future decisions in treatment strategies for patients with LAPC The Scandinavian healthcare context is well suited for performing multi-centre long-term prospective randomized clinical trials. Similar care protocols and a history of entirely tax-funded healthcare facilitate joint trials.
- Published
- 2018
15. Functional informed genome-wide interaction analysis of body mass index, diabetes and colorectal cancer risk
- Author
-
Xia, Z, Su, Y-R, Petersen, P, Qi, L, Kim, AE, Figueiredo, JC, Lin, Y, Nan, H, Sakoda, LC, Albanes, D, Berndt, SI, Bezieau, S, Bien, S, Buchanan, DD, Casey, G, Chan, AT, Conti, DV, Drew, DA, Gallinger, SJ, Gauderman, WJ, Giles, GG, Gruber, SB, Gunter, MJ, Hoffmeister, M, Jenkins, MA, Joshi, AD, Le Marchand, L, Lewinger, JP, Li, L, Lindor, NM, Moreno, V, Murphy, N, Nassir, R, Newcomb, PA, Ogino, S, Rennert, G, Song, M, Wang, X, Wolk, A, Woods, MO, Brenner, H, White, E, Slattery, ML, Giovannucci, EL, Chang-Claude, J, Pharoah, PDP, Hsu, L, Campbell, PT, Peters, U, Xia, Z, Su, Y-R, Petersen, P, Qi, L, Kim, AE, Figueiredo, JC, Lin, Y, Nan, H, Sakoda, LC, Albanes, D, Berndt, SI, Bezieau, S, Bien, S, Buchanan, DD, Casey, G, Chan, AT, Conti, DV, Drew, DA, Gallinger, SJ, Gauderman, WJ, Giles, GG, Gruber, SB, Gunter, MJ, Hoffmeister, M, Jenkins, MA, Joshi, AD, Le Marchand, L, Lewinger, JP, Li, L, Lindor, NM, Moreno, V, Murphy, N, Nassir, R, Newcomb, PA, Ogino, S, Rennert, G, Song, M, Wang, X, Wolk, A, Woods, MO, Brenner, H, White, E, Slattery, ML, Giovannucci, EL, Chang-Claude, J, Pharoah, PDP, Hsu, L, Campbell, PT, and Peters, U
- Abstract
BACKGROUND: Body mass index (BMI) and diabetes are established risk factors for colorectal cancer (CRC), likely through perturbations in metabolic traits (e.g. insulin resistance and glucose homeostasis). Identification of interactions between variation in genes and these metabolic risk factors may identify novel biologic insights into CRC etiology. METHODS: To improve statistical power and interpretation for gene-environment interaction (G × E) testing, we tested genetic variants that regulate expression of a gene together for interaction with BMI (kg/m2 ) and diabetes on CRC risk among 26 017 cases and 20 692 controls. Each variant was weighted based on PrediXcan analysis of gene expression data from colon tissue generated in the Genotype-Tissue Expression Project for all genes with heritability ≥1%. We used a mixed-effects model to jointly measure the G × E interaction in a gene by partitioning the interactions into the predicted gene expression levels (fixed effects), and residual G × E effects (random effects). G × BMI analyses were stratified by sex as BMI-CRC associations differ by sex. We used false discovery rates to account for multiple comparisons and reported all results with FDR <0.2. RESULTS: Among 4839 genes tested, genetically predicted expressions of FOXA1 (P = 3.15 × 10-5 ), PSMC5 (P = 4.51 × 10-4 ) and CD33 (P = 2.71 × 10-4 ) modified the association of BMI on CRC risk for men; KIAA0753 (P = 2.29 × 10-5 ) and SCN1B (P = 2.76 × 10-4 ) modified the association of BMI on CRC risk for women; and PTPN2 modified the association between diabetes and CRC risk in both sexes (P = 2.31 × 10-5 ). CONCLUSIONS: Aggregating G × E interactions and incorporating functional information, we discovered novel genes that may interact with BMI and diabetes on CRC risk.
- Published
- 2020
16. Benefit and harm of pregabalin in acute pain treatment:a systematic review with meta-analyses and trial sequential analyses
- Author
-
Fabritius, M L, Strøm, C, Koyuncu, S, Jæger, P, Petersen, P L, Geisler, A, Wetterslev, J, Dahl, J B, Mathiesen, O, Fabritius, M L, Strøm, C, Koyuncu, S, Jæger, P, Petersen, P L, Geisler, A, Wetterslev, J, Dahl, J B, and Mathiesen, O
- Abstract
Pregabalin has demonstrated anti-hyperalgesic properties and was introduced into acute pain treatment in 2001. Our aim was to evaluate the beneficial and harmful effects of pregabalin in postoperative pain management. We included randomized clinical trials investigating perioperative pregabalin treatment in adult surgical patients. The review followed Cochrane methodology, including Grading of Recommendations Assessment, Development, and Evaluation (GRADE), and used trial sequential analyses (TSAs). The primary outcomes were 24 h morphine i.v. consumption and the incidence of serious adverse events (SAEs) defined by International Conference of Harmonisation Good Clinical Practice guidelines. Conclusions were based primarily on trials with low risk of bias. Ninety-seven randomized clinical trials with 7201 patients were included. The 24 h morphine i.v. consumption was reported in 11 trials with overall low risk of bias, finding a reduction of 5.8 mg (3.2, 8.5; TSA adjusted confidence interval: 3.2, 8.5). Incidence of SAEs was reported in 21 trials, with 55 SAEs reported in 12 of these trials, and 22 SAEs reported in 10 trials with overall low risk of bias. In trials with overall low risk of bias, Peto's odds ratio was 2.9 (1.2, 6.8; TSA adjusted confidence interval: 0.1, 97.1). Based on trials with low risk of bias, pregabalin may have a minimal opioid-sparing effect, but the risk of SAEs seems increased. However, the GRADE-rated evaluations showed only moderate to very low quality of evidence. Consequently, a routine use of pregabalin for postoperative pain treatment cannot be recommended.
- Published
- 2017
17. Delirium after fast-track hip and knee arthroplasty – a cohort study of 6331 elderly patients
- Author
-
Petersen, P. B., Jørgensen, C. C., Kehlet, H., Madsen, Frank, Hansen, Torben B., Husted, Henrik, Laursen, Mogens B., Hansen, Lars T., Kjærsgaard-Andersen, Per, Solgaard, Søren, Petersen, P. B., Jørgensen, C. C., Kehlet, H., Madsen, Frank, Hansen, Torben B., Husted, Henrik, Laursen, Mogens B., Hansen, Lars T., Kjærsgaard-Andersen, Per, and Solgaard, Søren
- Abstract
Background: Postoperative delirium (PD) is a well-known complication among elderly surgical patients and associated with increased morbidity, mortality and length of stay (LOS). In elective orthopedic surgery, including hip and knee arthroplasty (THA/TKA), most studies report incidences between 5% and 10%. The multimodal optimization of perioperative care (fast-track) aims to enhance recovery and reduce morbidity and LOS, but limited data are available on the effect on PD. Consequently, the study investigated signs of PD associated with LOS > 4 days. Methods: Prospective risk assessment study with retrospective analysis of discharge notes or medical records of signs of PD in 6331 elective primary unilateral THA and TKA patients ≥ 70 years, and LOS > 4 days. Preoperative patient characteristics collected from eight high volume centers with similar standardized fast-track protocols from January 2010 to November 2013. Results: We identified 43 (0.7%) cases of PD symptoms mentioned as a reason for LOS > 4 days among the 789 patients with LOS > 4 days (12.5% of all THA and TKA). PD patients had a mean age of 80.7 [[95% CI] 79.3–82.1] years, being 4.0 [[95% CI] 2.5–5.5] years older compared to patients without PD (P < 0.001). LOS was median 10 [[Q2–Q3] 7–14] days in the PD group vs. 3 [2–3] days in the non-PD group (P < 0.001), without differences in gender or site of arthroplasty (P = 0.139 and 0.499, respectively). Conclusion: Postoperative delirium symptoms contributing to LOS > 4 days in fast-track THA and TKA are rare in elderly patients.
- Published
- 2017
18. Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases:analysis of an international multicenter database
- Author
-
Keizman, D, Fosboel, M O, Reichegger, H, Peer, A, Rosenbaum, E, Desax, M-C, Neiman, V, Petersen, P M, Mueller, J, Cathomas, R, Gottfried, M, Dresler, H, Sarid, D, Mermershtain, W, Rouvinov, K, Mortensen, J, Gillessen, S, Daugaard, G, Omlin, A, Keizman, D, Fosboel, M O, Reichegger, H, Peer, A, Rosenbaum, E, Desax, M-C, Neiman, V, Petersen, P M, Mueller, J, Cathomas, R, Gottfried, M, Dresler, H, Sarid, D, Mermershtain, W, Rouvinov, K, Mortensen, J, Gillessen, S, Daugaard, G, and Omlin, A
- Abstract
BACKGROUND: The imaging response to radium-223 therapy is at present poorly described. We aimed to describe the imaging response to radium-223 treatment.METHODS: We retrospectively evaluated the computed tomography (CT) and bone scintigraphy response of metastatic castration-resistant prostate cancer (CRPC) patients treated with radium-223, in eight centers in three countries.RESULTS: A total of 130 patients were included, the majority (n=84, 65%) received radium-223 post docetaxel. Thirty-four of 99 patients with available data (34%) received concomitant abiraterone or enzalutamide. A total of 54% (n=70) patients completed the planned six injections of radium-223. In patients with available data, a transient increase in bone metastases-related pain was observed in 27% (n=33/124) and an improvement of bone metastases-related pain on treatment with radium-223 was noted in 49% of patients (n=61/124). At 3 and 6 months of treatment with radium-223, bone imaging showed stable disease in 74% (n=84/113) and 94% of patients (n=93/99) with available data, respectively. An increase in the number of bone lesions was documented at 3 months compared with baseline in 26% (n=29/113) and at 6 months compared with 3 months in 6% of patients (n=6/99), respectively. Radiological extraskeletal disease progression occurred in 46% of patients (n=57/124) with available CT data at 3 and/or 6 months.CONCLUSIONS: Progression of bone metastases during radium-223 therapy is uncommon. A bone flare (pain and/or radiological) may be noted during the first 3 months, and should not be confused with progression. Imaging by CT scan should be considered after three and six doses of radium-223 to rule out extraskeletal disease progression.
- Published
- 2017
19. Prevalence and severity of hip and groin pain in sub-elite male football:a cross-sectional cohort study of 695 players
- Author
-
Thorborg, K, Rathleff, M S, Petersen, P., Branci, S., Hölmich, P, Thorborg, K, Rathleff, M S, Petersen, P., Branci, S., and Hölmich, P
- Abstract
The purpose of this study was twofold: (a) to investigate the prevalence of hip and groin pain in sub-elite male adult football in Denmark and (b) to explore the association between prevalence and duration of hip and groin pain in the previous season with the Copenhagen Hip and Groin Outcome Score (HAGOS) in the beginning of the new season. In total 695 respondents from 40 teams (Division 1-4) were included. Players completed in the beginning of the new season (July-Sept 2011) a self-reported paper questionnaire on hip and/or groin pain during the previous season and HAGOS. In total 49% (95% CI: 45-52%) reported hip and/or groin pain during the previous season. Of these, 31% (95% CI: 26-36%) reported pain for >6 weeks. Players with the longest duration of pain during the previous season had the lowest HAGOS scores, when assessed at the beginning of the new season, P < 0.001. This study documents that half of sub-elite male adult football players report pain in the hip and/or groin during a football season. The football players with the longest duration of pain in previous season displayed the lowest HAGOS scores in the beginning of the new season.
- Published
- 2017
20. Extraction of digital wavefront sets using applied harmonic analysis and deep neural networks
- Author
-
Andrade-Loarca, H., Kutyniok, G., Öktem, Ozan, Petersen, P., Andrade-Loarca, H., Kutyniok, G., Öktem, Ozan, and Petersen, P.
- Abstract
Microlocal analysis provides deep insight into singularity structures and is often crucial for solving inverse problems, predominately, in imaging sciences. Of particular importance is the analysis of wavefront sets and the correct extraction of those. In this paper, we introduce the first algorithmic approach to extract the wavefront set of images, which combines data-based and model-based methods. Based on a celebrated property of the shearlet transform to unravel information on the wavefront set, we extract the wavefront set of an image by first applying a discrete shearlet transform and then feeding local patches of this transform to a deep convolutional neural network trained on labeled data. The resulting algorithm outperforms all competing algorithms in edge-orientation and ramp-orientation detection., QC 20200506
- Published
- 2019
- Full Text
- View/download PDF
21. Multiple-μJ mid-IR supercontinuum generation in quadratic nonlinear crystals
- Author
-
Bache, Morten, Zhou, Binbin, Ashihara, S., Stingel, A., Vanselous, H., Petersen, P. B., Bache, Morten, Zhou, Binbin, Ashihara, S., Stingel, A., Vanselous, H., and Petersen, P. B.
- Abstract
Pumping a quadratic nonlinear crystal in the mid-IR we observe octave-spanning mid-IR supercontinua. A self-acting cascaded process leads to the formation of a self-defocusing nonlinearity, allowing formation of filament-free octave-spanning supercontinua in the 2.0–7.0 μm range with 10s of μJ pulse energies, much higher than filament-based techniques. This allows to use the supercontinuum as ultra-broadband excitation pulses in nonlinear optical applications.
- Published
- 2016
22. Gabapentin for post-operative pain management - a systematic review with meta-analyses and trial sequential analyses
- Author
-
Fabritius, M L, Geisler, A, Petersen, P L, Nikolajsen, Lone, Hansen, M S, Kontinen, V, Hamunen, K, Dahl, J B, Wetterslev, J, Mathiesen, O, Fabritius, M L, Geisler, A, Petersen, P L, Nikolajsen, Lone, Hansen, M S, Kontinen, V, Hamunen, K, Dahl, J B, Wetterslev, J, and Mathiesen, O
- Abstract
BACKGROUND: Perioperative pain treatment often consist of combinations of non-opioid and opioid analgesics, 'multimodal analgesia', in which gabapentin is currently used. The aim was to document beneficial and harmful effects of perioperative gabapentin treatment.METHODS: Randomized clinical trials comparing gabapentin vs. placebo or active placebo in adult surgical patients receiving gabapentin perioperatively were included. This review was conducted using Cochrane standards, trial sequential analysis (TSA), and Grading of Recommendations Assessment, Development, and Evaluation (GRADE). The primary outcomes were 24-h opioid consumption and incidence of serious adverse events (SAE).RESULTS: One hundred and thirty-two trials with 9498 patients were included. Thirteen trials with low risk of bias reported a reduction in 24-h opioid consumption of 3.1 mg [0.5, 5.6; TSA-adjusted CI: -0.2, 6.3]. In the analysis of gabapentin as add-on analgesic to another non-opioid analgesic regimen, a mean reduction in 24-h morphine consumption of 1.2 mg [-0.3, 2.6; TSA-adjusted CI: -0.4, 2.8] in trials with low risk of bias was found. Nine trials with low risk of bias reported a risk ratio of SAEs of 1.61 [0.91; 2.86; TSA-adjusted CI: 0.57, 4.57].CONCLUSION: Based on GRADE assessment of the primary outcomes in trials with low risk of bias, the results are low or very low quality of evidence due to imprecision, inconsistency, and in some outcomes indirectness. Firm evidence for use of gabapentin is lacking as clinically relevant beneficial effect of gabapentin may be absent and harm is imminent, especially when added to multimodal analgesia.
- Published
- 2016
23. Comparison of UVB and UVC irradiation disinfection efficacies on Pseudomonas Aeruginosa (P. aeruginosa) biofilm
- Author
-
Argyraki, A., Markvart, M., Nielsen, Anne, Bjarnsholt, T., Bjørndal, L., Petersen, P. M., Argyraki, A., Markvart, M., Nielsen, Anne, Bjarnsholt, T., Bjørndal, L., and Petersen, P. M.
- Abstract
Disinfection routines are important in all clinical applications. The uprising problem of antibiotic resistance has driven major research efforts towards alternative disinfection approaches, involving light-based solutions. Pseudomonas aeruginosa (P. aeruginosa) is a common bacterium that can cause skin, soft tissue, lungs, kidney and urinary tract infections. Moreover, it can be found on and in medical equipment causing often cross infections in hospitals. The objective of this study was to test the efficiency, of two different light-based disinfection treatments, namely UVB and UVC irradiation, on P. aeruginosa biofilms at different growth stages. In our experiments a new type of UV light emitting diodes (LEDs) were used to deliver UV irradiation on the biofilms, in the UVB (296nm) and UVC (266nm) region. The killing rate was studied as a function of dose for 24h grown biofilms. The dose was ramped from 72J/m2 to 10000J/m2. It was shown that UVB irradiation was more effective than UVC irradiation in inactivating P. aeruginosa biofilms. No colony forming units (CFU) were observed for the UVB treated biofilms when the dose was 10000 J/m2 (CFU in control sample: 7.5 x 104). UVB irradiation at a dose of 20000J/m2 on mature biofilms (72h grown) resulted in a 3.9 log killing efficacy. The fact that the wavelength of 296nm exists in daylight and has such disinfection ability on biofilms gives new perspectives for applications within disinfection at hospitals.
- Published
- 2016
24. Transversus abdominis plane (TAP) block after robot-assisted laparoscopic hysterectomy:a randomised clinical trial
- Author
-
Torup, H, Bøgeskov, M, Hansen, E G, Palle, C, Rosenberg, J, Mitchell, A. U., Petersen, P L, Mathiesen, O, Dahl, J B, Møller, A M, Torup, H, Bøgeskov, M, Hansen, E G, Palle, C, Rosenberg, J, Mitchell, A. U., Petersen, P L, Mathiesen, O, Dahl, J B, and Møller, A M
- Abstract
Background Transversus abdominis plane (TAP) block is widely used as a part of pain management after various abdominal surgeries. We evaluated the effect of TAP block as an add-on to the routine analgesic regimen in patients undergoing robot-assisted laparoscopic hysterectomy. Methods In a prospective blinded study, 70 patients scheduled for elective robot-assisted laparoscopic hysterectomy were randomised to receive either TAP block (ropivacaine 0.5%, 20 ml on each side) or sham block (isotonic saline 0.9%, 20 ml on each side). All patients had patient-controlled analgesia (PCA) with morphine on top of paracetamol and ibuprofen or diclofenac. For the first 24 post-operative hours, we monitored PCA morphine consumption and pain scores with visual analogue scale (VAS) at rest and while coughing. Post-operative nausea and number of vomits (PONV) were recorded. Results Sixty-five patients completed the study, 34 receiving TAP block with ropivacaine and 31 receiving sham block with isotonic saline. We found no differences in median (interquartile range) morphine consumption the first 24 h between the TAP block group [17.5 mg (6.9–36.0 mg)] and the placebo group [17.5 mg (2.9–38.0 mg)] (95% confidence interval 10.0–22.6 mg, P = 0.648). No differences were found for VAS scores between the two groups, calculated as area under the curve/1–24 h, neither at rest (P = 0.112) nor while coughing (P = 0.345), or for PONV between groups. Conclusions In our study, the TAP block combined with paracetamol and Nonsteroidal anti-inflammatory drugs (NSAID) treatment, had no effect on morphine consumption, VAS pain scores, or frequency of nausea and vomiting after robot-assisted laparoscopic hysterectomy compared with paracetamol and NSAID alone., BACKGROUND: Transversus abdominis plane (TAP) block is widely used as a part of pain management after various abdominal surgeries. We evaluated the effect of TAP block as an add-on to the routine analgesic regimen in patients undergoing robot-assisted laparoscopic hysterectomy.METHODS: In a prospective blinded study, 70 patients scheduled for elective robot-assisted laparoscopic hysterectomy were randomised to receive either TAP block (ropivacaine 0.5%, 20 ml on each side) or sham block (isotonic saline 0.9%, 20 ml on each side). All patients had patient-controlled analgesia (PCA) with morphine on top of paracetamol and ibuprofen or diclofenac. For the first 24 post-operative hours, we monitored PCA morphine consumption and pain scores with visual analogue scale (VAS) at rest and while coughing. Post-operative nausea and number of vomits (PONV) were recorded.RESULTS: Sixty-five patients completed the study, 34 receiving TAP block with ropivacaine and 31 receiving sham block with isotonic saline. We found no differences in median (interquartile range) morphine consumption the first 24 h between the TAP block group [17.5 mg (6.9-36.0 mg)] and the placebo group [17.5 mg (2.9-38.0 mg)] (95% confidence interval 10.0-22.6 mg, P = 0.648). No differences were found for VAS scores between the two groups, calculated as area under the curve/1-24 h, neither at rest (P = 0.112) nor while coughing (P = 0.345), or for PONV between groups.CONCLUSIONS: In our study, the TAP block combined with paracetamol and Nonsteroidal anti-inflammatory drugs (NSAID) treatment, had no effect on morphine consumption, VAS pain scores, or frequency of nausea and vomiting after robot-assisted laparoscopic hysterectomy compared with paracetamol and NSAID alone.
- Published
- 2015
25. SPCG-15 : a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer
- Author
-
Stranne, J., Brasso, K., Brennhovd, B., Johansson, Eva, Jäderling, F., Kouri, M., Lilleby, W., Petersen, P. Meidahl, Mirtti, T., Pettersson, A., Rannikko, A., Thellenberg, C., Akre, O., Stranne, J., Brasso, K., Brennhovd, B., Johansson, Eva, Jäderling, F., Kouri, M., Lilleby, W., Petersen, P. Meidahl, Mirtti, T., Pettersson, A., Rannikko, A., Thellenberg, C., and Akre, O.
- Abstract
Objective: To describe study design and procedures for a prospective randomized trial investigating whether radical prostatectomy (RP) ± radiation improves cause-specific survival in comparison with primary radiation treatment (RT) and androgen deprivation treatment (ADT) in patients with locally advanced prostate cancer (LAPC). Materials and methods: SPCG-15 is a prospective, multi-centre, open randomized phase III trial. Patients are randomized to either standard (RT + ADT) or experimental (RP with extended pelvic lymph-node dissection and with addition of adjuvant or salvage RT and/or ADT if deemed necessary) treatment. Each centre follows guidelines regarding the timing and dosing of postoperative RT and adjuvant treatment such as ADT The primary endpoint is cause-specific survival. Secondary endpoints include metastasis-free and overall survival, quality-of-life, functional outcomes and health-services requirements. Each subject will be followed up for a minimum of 10 years. Results: Twenty-three centres in Denmark, Finland, Norway and Sweden, well established in performing RP and RT for prostate cancer participated. Each country’s sites were coordinated by national coordinating investigators and sub-investigators for urology and oncology. Almost 400 men have been randomized of the stipulated 1200, with an increasing rate of accrual. Conclusions: The SPCG-15 trial aims to compare the two curatively intended techniques supplying new knowledge to support future decisions in treatment strategies for patients with LAPC The Scandinavian healthcare context is well suited for performing multi-centre long-term prospective randomized clinical trials. Similar care protocols and a history of entirely tax-funded healthcare facilitate joint trials.
- Published
- 2018
- Full Text
- View/download PDF
26. HASH(0x563d440443a8)
- Author
-
Wild, C., Blagojevic, S., Petersen, P., Wild, C., Blagojevic, S., and Petersen, P.
- Published
- 2018
27. HASH(0x55d8445e9310)
- Author
-
Wild, C., Blagojevic, S., Petersen, P., Wild, C., Blagojevic, S., and Petersen, P.
- Published
- 2018
28. HASH(0x558738ca6b10)
- Author
-
Wild, C., Blagojevic, S., Petersen, P., Wild, C., Blagojevic, S., and Petersen, P.
- Published
- 2018
29. HASH(0x558739324358)
- Author
-
Wild, C., Blagojevic, S., Petersen, P., Wild, C., Blagojevic, S., and Petersen, P.
- Published
- 2018
30. Doses to head and neck normal tissues for early stage Hodgkin lymphoma after involved node radiotherapy
- Author
-
Maraldo, M. V., Brodin, N. P., Aznar, M. C., Vogelius, I. R., af Rosenschold, P. Munck, Petersen, P. M., Specht, L., Maraldo, M. V., Brodin, N. P., Aznar, M. C., Vogelius, I. R., af Rosenschold, P. Munck, Petersen, P. M., and Specht, L.
- Published
- 2014
31. Budapest Declaration:IADR-GOHIRA(R)
- Author
-
Mossey, P A, Petersen, P E, Mossey, P A, and Petersen, P E
- Published
- 2014
32. Doses to head and neck normal tissues for early stage Hodgkin lymphoma after involved node radiotherapy
- Author
-
Maraldo, M. V., Brodin, N. P., Aznar, M. C., Vogelius, I. R., af Rosenschold, P. Munck, Petersen, P. M., Specht, L., Maraldo, M. V., Brodin, N. P., Aznar, M. C., Vogelius, I. R., af Rosenschold, P. Munck, Petersen, P. M., and Specht, L.
- Published
- 2014
33. Budapest Declaration:IADR-GOHIRA(R)
- Author
-
Mossey, P A, Petersen, P E, Mossey, P A, and Petersen, P E
- Published
- 2014
34. Promoting oral health of children through schools--results from a WHO global survey 2012
- Author
-
Jürgensen, N, Petersen, P E, Jürgensen, N, and Petersen, P E
- Abstract
This paper reviews the range of school-based approaches to oral health and describes what is meant by a Health Promoting School. The paper then reports the results of a World Health Organization global survey of school-based health promotion. Purposive sampling across 100 countries produced 108 evaluations of school oral health projects spread across 61 countries around the globe. The Ottawa Charter for Health Promotion noted that schools can provide a supportive environment for promoting children's health. However, while a number of well-known strategies are being applied, the full range of health promoting actions is not being used globally. A greater emphasis on integrated health promotion is advised in place of narrower, disease- or project-specific approaches. Recommendations are made for improving this situation, for further research and for specifying an operational framework for sharing experiences and research.
- Published
- 2013
35. Treatment with docetaxel and cisplatin in advanced adrenocortical carcinoma, a phase II study
- Author
-
Urup, Thomas, Pawlak, W Z, Petersen, P M, Pappot, H, Rørth, M, Daugaard, G, Urup, Thomas, Pawlak, W Z, Petersen, P M, Pappot, H, Rørth, M, and Daugaard, G
- Published
- 2013
36. Innovations in materials for direct restorations:why do we need innovations? Why is it so hard to capitalize on them?
- Author
-
Rekow, E D, Fox, C H, Petersen, P E, Watson, T, Rekow, E D, Fox, C H, Petersen, P E, and Watson, T
- Published
- 2013
37. The challenge for innovation in direct restorative materials
- Author
-
Bayne, S, Petersen, P E, Piper, D, Schmalz, G, Meyer, D, Bayne, S, Petersen, P E, Piper, D, Schmalz, G, and Meyer, D
- Abstract
During the past 50 years, a series of key UN conferences have established a framework to minimize human health risks from environmental exposures to key chemicals. In January 2013, more than 140 countries agreed to the text of new treaty to minimize Hg effects on the environment (the Minamata Convention). Dental caries is omnipresent around the globe, affecting 60% to 90% of school children and most adults, and producing discomfort that affects quality of life. Dental amalgam is frequently used to treat carious lesions and its use releases mercury into the environment. The best way to avoid the use of dental amalgam is to emphasize caries prevention. Alternatives to amalgam are suitable in some applications, but no replacement for amalgam has been found for large posterior restorations. For any restorative material, safety and environmental impacts are part of clinical risk assessment. Safety is freedom from unacceptable risks. Risk is a combination of probability of exposure and severity of harm. Best management practices are crucial to manage dental amalgam, but these impose additional that are disproportionately more for developing countries. The Minamata Convention seeks a phase-out of all mercury-based products except dental amalgam, where a phase-down is the present goal. For dentistry, the most important focus is the promotion of caries prevention and research on new materials.
- Published
- 2013
38. Future innovation and research in dental restorative materials
- Author
-
Rekow, E D, Fox, C H, Watson, T, Petersen, P E, Rekow, E D, Fox, C H, Watson, T, and Petersen, P E
- Published
- 2013
39. Treatment with docetaxel and cisplatin in advanced adrenocortical carcinoma, a phase II study
- Author
-
Urup, Thomas, Pawlak, W Z, Petersen, P M, Pappot, H, Rørth, M, Daugaard, G, Urup, Thomas, Pawlak, W Z, Petersen, P M, Pappot, H, Rørth, M, and Daugaard, G
- Published
- 2013
40. Promoting oral health of children through schools--results from a WHO global survey 2012
- Author
-
Jürgensen, N, Petersen, P E, Jürgensen, N, and Petersen, P E
- Abstract
This paper reviews the range of school-based approaches to oral health and describes what is meant by a Health Promoting School. The paper then reports the results of a World Health Organization global survey of school-based health promotion. Purposive sampling across 100 countries produced 108 evaluations of school oral health projects spread across 61 countries around the globe. The Ottawa Charter for Health Promotion noted that schools can provide a supportive environment for promoting children's health. However, while a number of well-known strategies are being applied, the full range of health promoting actions is not being used globally. A greater emphasis on integrated health promotion is advised in place of narrower, disease- or project-specific approaches. Recommendations are made for improving this situation, for further research and for specifying an operational framework for sharing experiences and research.
- Published
- 2013
41. Innovations in materials for direct restorations:why do we need innovations? Why is it so hard to capitalize on them?
- Author
-
Rekow, E D, Fox, C H, Petersen, P E, Watson, T, Rekow, E D, Fox, C H, Petersen, P E, and Watson, T
- Published
- 2013
42. Future innovation and research in dental restorative materials
- Author
-
Rekow, E D, Fox, C H, Watson, T, Petersen, P E, Rekow, E D, Fox, C H, Watson, T, and Petersen, P E
- Published
- 2013
43. The challenge for innovation in direct restorative materials
- Author
-
Bayne, S, Petersen, P E, Piper, D, Schmalz, G, Meyer, D, Bayne, S, Petersen, P E, Piper, D, Schmalz, G, and Meyer, D
- Abstract
During the past 50 years, a series of key UN conferences have established a framework to minimize human health risks from environmental exposures to key chemicals. In January 2013, more than 140 countries agreed to the text of new treaty to minimize Hg effects on the environment (the Minamata Convention). Dental caries is omnipresent around the globe, affecting 60% to 90% of school children and most adults, and producing discomfort that affects quality of life. Dental amalgam is frequently used to treat carious lesions and its use releases mercury into the environment. The best way to avoid the use of dental amalgam is to emphasize caries prevention. Alternatives to amalgam are suitable in some applications, but no replacement for amalgam has been found for large posterior restorations. For any restorative material, safety and environmental impacts are part of clinical risk assessment. Safety is freedom from unacceptable risks. Risk is a combination of probability of exposure and severity of harm. Best management practices are crucial to manage dental amalgam, but these impose additional that are disproportionately more for developing countries. The Minamata Convention seeks a phase-out of all mercury-based products except dental amalgam, where a phase-down is the present goal. For dentistry, the most important focus is the promotion of caries prevention and research on new materials.
- Published
- 2013
44. Low-Dose Total Skin Electron Beam Therapy as a Debulking Agent for Cutaneous T-Cell Lymphoma: An open-label prospective phase II study
- Author
-
Kamstrup, M R, Lindahl, Lise Maria, Gniadecki, R, Iversen, Lars, Skov, L, Petersen, P M, Loft, Annika, Specht, L, Kamstrup, M R, Lindahl, Lise Maria, Gniadecki, R, Iversen, Lars, Skov, L, Petersen, P M, Loft, Annika, and Specht, L
- Abstract
Background: Total skin electron beam therapy (TSEBT) is a powerful treatment for cutaneous T-cell lymphomas (CTCL). Based on the occurrence of relapses with low radiation doses, doses of 30-36 Gy are commonly used but most patients still eventually relapse and repeat treatment courses are limited due to the cumulative toxicity. Complete response rates are about 60-90% for T2-4 stages with a 5-year relapse-free survival of 10-25% for stages IB-III. Objectives: To evaluate prospectively the efficacy of low-dose TSEBT (10 Gy) in terms of complete cutaneous response rate, overall response rate and response duration in CTCL. Methods: Ten patients with stage IB-IV mycosis fungoides (MF) were treated in an open-label manner with 4 fractions of 1 Gy/week TSEB to a total skin dose of 10 Gy. Treatment responses were assessed at 1 and 3 months after treatment and subsequently at least every 6 months for a total period of 2 years or to disease relapse or progression. Results: Patients achieved an overall response rate of 90%. The rate of the complete response (CR) or very good partial response (VGPR
- Published
- 2012
45. Community-oriented administration of fluoride for the prevention of dental caries:a summary of the current situation in Asia
- Author
-
Petersen, P E, Baez, R J, Lennon, M A, Petersen, P E, Baez, R J, and Lennon, M A
- Abstract
Dental caries is the most prevalent chronic disease affecting human populations around the world. It is recognized that fluoride plays a significant role in dental caries reduction. Meanwhile, several low- and middle-income countries of Asia have not yet implemented systematic fluoride programs; contributing factors relate to misconceptions about the mechanisms of fluoride, low priority given to oral health in national health policy and strategic plans, and lack of interest among public health administrators. A workshop on the effective use of fluoride in Asia took place in Phang-Nga, Thailand, in 2011. A series of country presentations addressed some of the topics mentioned above; in addition, speakers from countries of the region provided examples of successful fluoride interventions and discussed program limitations, barriers encountered, and solutions, as well as possibilities for expanding coverage. Participants acknowledged that automatic fluoridation through water, salt, and milk is the most effective and equitable strategy for the prevention of dental caries. Concerns were expressed that government-subsidized community fluoride prevention programs may face privatization. In addition, the use of affordable fluoride-containing toothpastes should be encouraged. The workshop identified: strengths and weaknesses of ongoing community-based fluoride programs, as well as the interest of countries in a particular method; the requirement for World Health Organization (WHO) technical assistance on various aspects, including fluoridation process, feasibility studies, and implementation of effective epidemiological surveillance of the program; exchange of information; and the need for inter-country collaboration. It was acknowledged that program process and evaluation at the local and country levels need further dissemination. The meeting was co-sponsored by the World Health Organization, the International Association for Dental Research, and the World Dental Federation.
- Published
- 2012
46. Clinical evaluation of three caries removal approaches in primary teeth:a randomised controlled trial
- Author
-
Phonghanyudh, A, Phantumvanit, P, Songpaisan, Y, Petersen, P E, Phonghanyudh, A, Phantumvanit, P, Songpaisan, Y, and Petersen, P E
- Abstract
To evaluate the clinical performance and radiographic outcome of glass ionomer cement (GIC) restoration in primary molars using three caries removal techniques.
- Published
- 2012
47. Socio-economic inequality in oral healthcare coverage:results from the World Health Survey
- Author
-
Hosseinpoor, A R, Itani, L, Petersen, P E, Hosseinpoor, A R, Itani, L, and Petersen, P E
- Abstract
The objective of this study was to assess socio-economic inequality in oral healthcare coverage among adults with expressed need living in 52 countries. Data on 60,332 adults aged 18 years or older were analyzed from 52 countries participating in the 2002-2004 World Health Survey. Oral healthcare coverage was defined as the proportion of individuals who received any medical care from a dentist or other oral health specialist during a period of 12 months prior to the survey, among those who expressed any mouth and/or teeth problems during that period. In addition to assessment of the coverage across wealth quintiles in each country, a wealth-based relative index of inequality was used to measure socio-economic inequality. The index was adjusted for sex, age, marital status, education, employment, overall health status, and urban/rural residence. Pro-rich inequality in oral healthcare coverage was observed within most of the countries, although lower income countries showed greater levels of relative inequality than higher income countries. Overall, lowest coverage and highest relative inequality were found in the low-income countries. The findings of this study may inform policies for oral health at global and national levels. To achieve universal coverage in oral healthcare, relevant interventions should reach the poorest population groups.
- Published
- 2012
48. Toward effective use of fluoride in Asia
- Author
-
Petersen, P E, Phantumvanit, P, Petersen, P E, and Phantumvanit, P
- Published
- 2012
49. Perspectives in the effective use of fluoride in Asia
- Author
-
Petersen, P E, Phantumvanit, P, Petersen, P E, and Phantumvanit, P
- Abstract
Dental caries is the most prevalent chronic disease affecting human populations worldwide. The diverse disease patterns across and within countries are related to socio-behavioral determinants, demographic factors, environmental conditions, and the availability and accessibility of oral health services, in particular, exposure to disease prevention programs (Petersen, 2003, 2008a). Benefits of fluoride for caries prevention have been substantiated in many countries (Petersen and Lennon, 2004; Jones et al., 2005). In the second half of the 20th century, this focus shifted to the development and evaluation of fluoride toothpastes and rinses and, to a lesser extent, to alternatives to water fluoridation, such as salt and milk fluoridation. Most recently, efforts have been made to summarize this extensive database through systematic reviews of fluoride administration (McDonagh et al., 2000; Marinho et al., 2003; Australian Government, 2007). The Asian workshop held in Phan-Nga, Thailand, during March 22-24, 2011, aimed to discuss current information on fluoride and dental caries, as well as to try identifying barriers and opportunities that countries of Asia may have for implementing such programs. In addition, the intention was to give recommendations for including fluoride schemes within national public health programs.
- Published
- 2012
50. Low-Dose Total Skin Electron Beam Therapy as a Debulking Agent for Cutaneous T-Cell Lymphoma: An open-label prospective phase II study
- Author
-
Kamstrup, M R, Lindahl, Lise Maria, Gniadecki, R, Iversen, Lars, Skov, L, Petersen, P M, Loft, Annika, Specht, L, Kamstrup, M R, Lindahl, Lise Maria, Gniadecki, R, Iversen, Lars, Skov, L, Petersen, P M, Loft, Annika, and Specht, L
- Abstract
Background: Total skin electron beam therapy (TSEBT) is a powerful treatment for cutaneous T-cell lymphomas (CTCL). Based on the occurrence of relapses with low radiation doses, doses of 30-36 Gy are commonly used but most patients still eventually relapse and repeat treatment courses are limited due to the cumulative toxicity. Complete response rates are about 60-90% for T2-4 stages with a 5-year relapse-free survival of 10-25% for stages IB-III. Objectives: To evaluate prospectively the efficacy of low-dose TSEBT (10 Gy) in terms of complete cutaneous response rate, overall response rate and response duration in CTCL. Methods: Ten patients with stage IB-IV mycosis fungoides (MF) were treated in an open-label manner with 4 fractions of 1 Gy/week TSEB to a total skin dose of 10 Gy. Treatment responses were assessed at 1 and 3 months after treatment and subsequently at least every 6 months for a total period of 2 years or to disease relapse or progression. Results: Patients achieved an overall response rate of 90%. The rate of the complete response (CR) or very good partial response (VGPR
- Published
- 2012
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.